Publications by authors named "Rinus Wanders"

Claim this Profile
I
Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study.
Dirk De Ruysscher, Angela van Baardwijk, Rinus Wanders, Lizza E Hendriks, Bart Reymen

Radiother Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450).
Dirk De Ruysscher, Rinus Wanders, Lizza E Hendriks, Angela van Baardwijk, Bart Reymen

J Thorac Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative evaluation of autocontouring in clinical practice: A practical method using the Turing test.
Mark J Gooding, Annamarie J Smith, Maira Tariq, Paul Aljabar, Devis Peressutti, Rinus Wanders

Med Phys· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender and age make no difference in the re-irradiation of painful bone metastases: A secondary analysis of the NCIC CTG SC.20 randomized trial.
Ronald Chow, Keyue Ding, Vithusha Ganesh, Ralph M Meyer, Yvette M van der Linden, Rinus Wanders

Radiother Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard of care in high-dose radiotherapy for localized non-small cell lung cancer.
Dirk De Ruysscher, Maarten Lambrecht, Angela van Baardwijk, Stéphanie Peeters, Bart Reymen, Rinus Wanders

Acta Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is selective nodal irradiation in non-small cell lung cancer still safe when using IMRT? Results of a prospective cohort study.
Hanneke M A Martinussen, Bart Reymen, Rinus Wanders, Esther G C Troost, Anne-Marie C Dingemans

Radiother Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: a step toward individualized care and shared decision making.
Cary Oberije, Georgi Nalbantov, Andre Dekker, Liesbeth Boersma, Jacques Borger, Rinus Wanders

Radiother Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of concurrent individualized, isotoxic accelerated radiotherapy and cisplatin-vinorelbine-cetuximab in patients with stage III non-small-cell lung cancer.
Anne-Marie C Dingemans, Gerben Bootsma, Angela van Baardwijk, Bart Reymen, Rinus Wanders

J Thorac Oncol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR).
Bart Reymen, Angela van Baardwijk, Rinus Wanders, Jacques Borger, Anne-Marie C Dingemans

Radiother Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia imaging with [¹⁸F]HX4 PET in NSCLC patients: defining optimal imaging parameters.
Catharina M L Zegers, Wouter van Elmpt, Roel Wierts, Bart Reymen, Hoda Sharifi, Rinus Wanders

Radiother Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer.
Bart Reymen, Judith Van Loon, Angela van Baardwijk, Rinus Wanders, Jacques Borger

Int J Radiat Oncol Biol Phys· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State of the art radiation therapy for lung cancer 2012: a glimpse of the future.
Dirk De Ruysscher, José Belderbos, Bart Reymen, Wouter van Elmpt, Angela van Baardwijk, Rinus Wanders

Clin Lung Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review.
Angela van Baardwijk, Wolfgang A Tomé, Wouter van Elmpt, Søren M Bentzen, Bart Reymen, Rinus Wanders

Radiother Oncol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450).
Dirk De Ruysscher, Rinus Wanders, Angela van Baardwijk, Anne-Marie C Dingemans, Bart Reymen

J Thorac Oncol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: a prospective population-based study.
Dirk De Ruysscher, Angela van Baardwijk, Jessie Steevens, Anita Botterweck, Geert Bosmans, Rinus Wanders

Radiother Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study.
Rinus Wanders, Jessie Steevens, Anita Botterweck, Anne-Marie C Dingemans, Bart Reymen

Eur J Cancer· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer patients use hospital-based care until death: a further analysis of the Dutch Bone Metastasis Study.
Jan J Meeuse, Yvette M van der Linden, Wendy J Post, Rinus Wanders, Rijk O B Gans

J Palliat Med· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.
Judith van Loon, Dirk De Ruysscher, Rinus Wanders, Liesbeth Boersma, Jean Simons

Int J Radiat Oncol Biol Phys· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation.
Judith van Loon, Janneke P C Grutters, Rinus Wanders, Liesbeth Boersma, Anne-Marie C Dingemans

Eur J Cancer· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can we optimize chemo-radiation and surgery in locally advanced stage III non-small cell lung cancer based on evidence from randomized clinical trials? A hypothesis-generating study.
Dirk De Ruysscher, Cary Dehing, Søren M Bentzen, Ruud Houben, André Dekker, Rinus Wanders

Radiother Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot study.
Dirk De Ruysscher, Ans Houben, Hugo J W L Aerts, Cary Dehing, Rinus Wanders

Radiother Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL.
Madelon Pijls-Johannesma, Ruud Houben, Liesbeth Boersma, Janneke Grutters, Katarina Seghers, Rinus Wanders

Radiother Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan.
Hugo J W L Aerts, Angela A W van Baardwijk, Steven F Petit, Claudia Offermann, Judith van Loon, Rinus Wanders

Radiother Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
Cécile Le Péchoux, Ariane Dunant, Suresh Senan, Aaron Wolfson, Elisabeth Quoix, Rinus Wanders

Lancet Oncol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up with 18FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: a prospective study.
Judith van Loon, Janneke Grutters, Rinus Wanders, Liesbeth Boersma, Michel Oellers

Eur J Cancer· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis